{{Rsnum
|rsid=184234
|Chromosome=15
|position=100711514
|Orientation=plus
|GMAF=0.1685
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.0 | 40.7 | 51.3
| HCB | 0.0 | 9.5 | 90.5
| JPT | 0.0 | 16.8 | 83.2
| YRI | 0.7 | 25.9 | 73.5
| ASW | 3.5 | 31.6 | 64.9
| CHB | 0.0 | 9.5 | 90.5
| CHD | 0.0 | 6.4 | 93.6
| GIH | 3.0 | 19.0 | 78.0
| LWK | 4.5 | 30.0 | 65.5
| MEX | 6.9 | 34.5 | 58.6
| MKK | 10.3 | 39.7 | 50.0
| TSI | 7.8 | 28.4 | 63.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=1E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}